Abstract
87 - Preclinical characterization and antitumor efficacy of DS-6051b, a novel, orally available small molecule tyrosine kinase inhibitor of ROS1 and NTRKs
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have